fbpx Skip to main content

Member's Profile

Sophiris Bio Inc.

Location
1258 Prospect Street
La Jolla,   CA
92037
United States
Sector
Biotech
Membership Info
Membership Type: Industry
Membership Since: 2012
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Sophiris Bio Inc.
Biotech Company
Sophiris Bio Inc. is a late-stage clinical biopharmaceutical company developing topsalysin (PRX302) for the treatment of patients with urological diseases. Topsalysin has completed two Phase 2 clinical trials for the focal treatment of localized prostate cancer and has completed one Phase 3 study of topsalysin for the treatment of the lower urinary tract symptoms of benign prostatic hyperplasia (BPH). Topsalysin is a highly potent ablative agent that is selective and targeted in that it is only activated by enzymatically active PSA which is found in high concentrations in the transition zone of the prostate and in and around prostate tumor cells.
Related News
No related news posted by this Member